NAME Dr. Daniel Speidel
CANCER TYPE Leukaemia
INSTITUTION Children's Medical Research Institute
STATE New South Wales
GRANT TYPE Other
PROJECT TYPE Support
"We aim to validate a new diagnostic test that can fast-track patients with chemotherapy-resistant leukaemia towards alternative therapies. This will accelerate treatment, reduce suffering and increase the chance of a cure."
Daniel Speidel, Children's Medical Research Institute
